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bDepartment of Sciences for Health Promotion ‘‘G. D’Alessandro’’, University, Palermo, ItalyAbstractBackground: Stroke is a disabling disease. In elderly populations, stroke is the third leading cause of death and the primary cause of
reduction in or loss of functional ability and personal autonomy. Possible associations between levels of total serum cholesterol (TC) and
both incidence of stroke and functional outcomes after rehabilitation are still under study.
Objective: To detect positive and negative prognostic factors associated with functional outcomes in first-time stroke patients admitted
to an integrated home care rehabilitative program.
Methods: This study enrolled 141 patients with a first-time stroke who were admitted to a home care rehabilitation program. Primary
outcome measures were the Barthel activities of daily living (ADL) and mobility indices at the beginning and end of the rehabilitative
treatment. The impact of TC and other demographic and clinical variables was analyzed using bivariate and multivariate logistic regression
analyses.
Results: Age and Short Portable Mental Status Questionnaire (SPMSQ) score were negatively associated with functional outcome. In
contrast, elevated TC was positively associated with a better home rehabilitative treatment outcome. Barthel index score at admission was
negatively associated with outcomes assessed by the Barthel ADL index and age with outcomes assessed by the Barthel mobility index. In
a multivariate logistic regression analysis, SPMSQ score and elevated TC were significantly associated with outcome. Specifically, higher
SPMSQ scores were negatively associated with better rehabilitative treatment outcomes, whereas elevated TC was positively associated.
Conclusions: Elevated TC seems to be associated with better functional outcomes in patients with first-time stroke.  2012 Elsevier
Inc. All rights reserved.
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elderly populations, stroke is the third leading cause of
death and the primary cause of reduction in or loss of func-
tional ability and personal autonomy [1]. The huge social
burden of this disease highlights the importance of identi-
fying prognostic factors as early as possible, because
despite therapeutic advances, only a small percentage of
elderly stroke survivors achieve a full recovery and most
show varying degrees of reduced functional autonomy
[2]. This greatly affects their quality of life, often making
it unsatisfactory and jeopardizing previously satisfactory
household relationship dynamics [3].
According to data from the 2001 Italian National Insti-
tute of Statistics, approximately 196,000 new strokes occurThe authors report no conflicts of interest.
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doi:10.1016/j.dhjo.2011.11.003every year in Italy, with crude incidence rates ranging
between 1.5 and 2.8 per 1000 inhabitants. In addition,
a marked upward south to north trend is observed [4,5].
Incidence increases with age and peaks in the over 85 pop-
ulation [4,5]. The acute poststroke mortality rate is 23%,
and the mortality rate within 1 year is approximately 30%
[4,5]. It is estimated that 12%-15% of stroke survivors
are hospitalized in rehabilitation units, one third have
a severe disability and a marked limitation in activities of
daily living, 20% need assistance to walk, and 70% are
unable to return to their previous job [4,5].
Assessing factors that correlate with functional outcome
is an important issue in stroke and disability research.
Previous studies have shown a consistent relationship
between coronary heart disease and high total serum
cholesterol (TC) levels. The correlation between stroke
and TC remains unclear, and currently very little data are
available regarding the effect of cholesterol on survival in
patients after stroke [6,7]. Until today, few studies have
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TC and the incidence of stroke, and the epidemiologic data
are conflicting. However, the association between the treat-
ment of high TC and recurrence of stroke or mortality has
been actively investigated [8-10]. The Prospective Evalua-
tion of Pravastatin in the Elderly (PROSPER) study, which
investigated the impact of pravastatin treatment in 5804
elderly subjects with either a history of vascular disease
or a high-risk profile, found that after a mean follow-up
of 3.2 years, pravastatin treatment significantly reduced
the relative risk for fatal or nonfatal stroke by 15% [8].
More recently, the Stroke Prevention by Aggressive Reduc-
tion in Cholesterol Levels (SPARCL) trial, recruiting 4731
patients with a history of recent stroke or transient ischemic
attack (TIA), found that atorvastatin reduced the overall
incidence of stroke, despite a small increase in the inci-
dence of hemorrhagic stroke [9]. Finally, in a recent
systematic review examining interventions in the manage-
ment of serum lipids for preventing stroke recurrence, statin
therapy in patients with a history of ischemic stroke or TIA
was associated with a significant reduction in subsequent
major coronary events, but only a marginal reduction in
the risk of stroke recurrence (odds ratio [OR] 0.88, 95%
confidence interval [CI] 0.77-1.00) [8]. Accordingly, the
authors conclude that patients with ischemic stroke or
TIA should receive statins [10].
In Italy, in accordance with the national Guidelines on
Rehabilitation Activities [11,12], patients with stroke-
related disability are included, after their hospital
discharge, in an integrated social and health care pathway
aimed at eliminating or minimizing disability so that the
patient can reach the highest level of independence possible
in both their social and working life [11,12]. The primary
tool in this pathway is a customized rehabilitation program.
This program contains a specific plan created by a rehabili-
tation team that is coordinated by a physiatrist. Such
a customized rehabilitation program considers residual
and recoverable abilities, the needs and preferences of the
patients and their families, and possible obstacles to
program adherence. The program also defines the role of
the rehabilitation team, taking into consideration all actions
needed to achieve the planned outcome. Necessary actions
are determined by defining short-, medium-, and long-term
objectives and the expected timeline for reaching them. The
objectives are then periodically updated by the team ac-
cording to recovery progress. The rehabilitation program
identifies the healthcare workers involved in each interven-
tion and their specific roles [11,12].
The Geriatric Assessment and Integrated Home Care
(GAIHC) Unit of District 10 of the Regional Health
Agency (ASP6) of Palermo carried out a prospective
cohort study on elderly patients over 65 years having
a first-time stroke, who were admitted to home care after
hospital discharge. All patients were treated at home with
a customized rehabilitation program as summarized above
[11-12].Hypothesis
This study was conducted to detect associations of
demographic and clinical factors with functional outcomes
of patients treated at home after a stroke. In particular, the
role of TC as a prognostic factor was investigated.
Methods
This was a prospective cohort study that enrolled 141
patients having sustained a first-time stroke between
December 2007 and December 2009 in an inner-city area
of Palermo, Italy. All patients who were admitted to the
rehabilitative program of the GAIHC Unit at the Health
District 10, Local Health Authority 6 of Palermo, Italy,
were included, regardless of age, stroke severity, or comor-
bid conditions. The Unit is comprised of an internal medi-
cine specialist, a physiatrist, a social assistant, a registered
nurse, a physiotherapist, and a home healthcare nurse, in
collaboration with a geriatrician and a neuropsychiatrist
at the local district health clinic.
On both admission and discharge, all patients included in
the study were given a standardized evaluation based on
a multidimensional assessment including medical, sociode-
mographic, and environmental components, as well as func-
tional components related to activities of daily living (ADLs)
and mobility assessed with the Barthel scales [13-17]. A co-
morbidity index was calculated using the Cumulative Illness
Rating scale (CIRS), and the Short Portable Mental Status
Questionnaire (SPMSQ) was administered. A rehabilitation
program was formulated based on the collected data, i.e.,
information from the standardized clinical measures, labora-
tory tests results, and clinical impressions gathered from all
components of the GAIHC. Information was obtained from
relatives or caregivers when necessary.
Stroke was defined according to criteria set forth by the
World Health Organization [18]. Patients with TIAs or
subarachnoid hemorrhages were not included. Stroke type
(hemorrhage/infarct) and size and site of lesion were deter-
mined using computerized tomography (CT) scans.
The outcome of the rehabilitative treatment was quanti-
fied as percent change scores for both Barthel ADL and
mobility indices. These were found by calculating the ratio
of the mean difference between scores at the beginning and
end of the treatment period to the score at the beginning.
The following predictors of rehabilitative treatment
outcome were investigated: age, sex, stroke subtype accord-
ing to the Oxfordshire Community Stroke Project (OCSP)
classifications [19], diabetes mellitus, ischemic heart disease
(IHD), hypertension, and TC. Diabetes was considered
presentwhen a patient had knowndiabetesmellitus on admis-
sion or when their fasting plasma glucose level was O126
mg/dL on admission. IHD was present when a patient had
a history of IHD or when IHD had been diagnosed during
the hospital stay.Hypertensionwas classified as presentwhen
a patient had been diagnosed during the hospital stay, was
receiving antihypertensive treatment before admission, or
Table 1
Demographic and Clinical Characteristics of the Patients (n 5 141)
Variable Valuea
Female gender 85 (60.3)
Age 77.33 6 9.02
Hypercholesterolemia 32 (22.7)
Diabetes mellitus 51 (36.2)
Ischemic heart disease 68 (48.9)
Atrial fibrillation 11 (7.8)
Hypertension 117 (83.0)
CIRS comorbidity index 2.12 6 0.47
SPQMQ score 5.38 6 3.71






Admit Barthel ADL Index score 50.86 6 10.30
Admit Barthel mobility Index score 36.27 6 5.82
LACI5 Lacunar infarction; PACI 5 Partial anterior circulation infarc-
tion; POCI5 Posterior circulation infarction; TACI5 Total anterior circu-
lation infarction; ADL 5 Activities of Daily Living.
a Values are mean 6 SD or n (%) unless otherwise stated.
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detection of blood pressure>160/95 mm Hg. TC was deter-
mined in a blood sample drawn on admission to the home-
care rehabilitative treatment program, and a cutoff level of
200mg/dLwas used to classify patients as having high serum
TC levels. Statin use was not included as a prognostic factor
because statins were prescribed to only 3 patients.
Statistical analysis
Statistical analysis was performed using the software
programs EpiInfo ver. 3.5 (CDC, Atlanta, Georgia) and Sta-
tistica (StatSoft, Inc, Tulsa, Oklahoma). Descriptive analyses
were performed by calculating means with standard devia-
tions (SD), and frequencies, and then assessing differences
using 1-way analysis of variance (ANOVA) or Kruskal-
Wallis when appropriate, or a chi-square test or Fisher exact
test, respectively. Associations between the variables under
examination were evaluated using contingency tables. The
crude effect of each variable on treatment outcome was
initially analyzed; then multivariate logistic regression anal-
ysis was used to estimate the adjusted effects of the prog-
nostic factors, after dichotomizing the Barthel percent
changes into positive versus negative or zero values. The
statistical criterion for eliminating a variable from the model
was a significance level of 0.10. Age and sexwere considered
basic elements and retained in the model. Results of statis-
tical tests were considered significant for p values! 0.05.Results
Demographic and clinical characteristics of patients
Table 1 shows the demographic and clinical characteris-
tics of the participants, presented as mean 6 SD. The meanage at the time of stroke was 77.33 6 9.02 years, and the
sample was 60.3% female. The mean age for women was
79.46 6 8.52 years, and for men, 74.09 6 8.85 years
( p ! 0.001).
Patients with ischemic stroke did not significantly differ
from those with hemorrhagic stroke in age distribution
(ischemic versus hemorrhagic, 77.94 6 8.20 versus 74.48 6
11.92 years, p 5 0.08), comorbidity index (2.15 6 0.40
versus 2.02 6 0.69, p 5 0.21), SPMSQ value (5.36 6
3.65 versus 5.44 6 4.03, p 5 0.09), frequency of hyper-
tension (81.9% versus 88.0%, p 5 0.34), Barthel ADL or
mobility scores on admission (ADL: 50.65 6 10.26 versus
51.88 6 10.63, p 5 0.59), (mobility: 36.02 6 5.90 versus
37.44 6 5.35, p 5 0.27), or length of rehabilitative treat-
ment (70.31 6 35.65 versus 66.92 6 33.12 days, p 5
0.66). They differed slightly by gender (ischemic versus
hemorrhagic, percent female 63.8% versus 44.0%, p 5
0.05) and frequency of diabetes (39.7% versus 20.0%,
p 5 0.05).
Thirty-two subjects had been diagnosed with high TC,
but only 3 took medication for it. TC did not appear to
be significantly associated with ischemic stroke: high TC
was present in 29 of 116 (25.0%) patients having sustained
an ischemic stroke and 3 of 25 (12.0%) with hemorrhagic
stroke ( p 5 0.12). Considering the results obtained and
the relatively small proportion of hemorrhagic strokes,
stratification by stroke subtype was not plausible and the
subsequent analysis was performed on all patients regard-
less of stroke pathogenesis.Follow-up and prognostic factors
The mean length of the rehabilitative treatment period
was 69.71 6 35.12 days. The outcome of the rehabilitative
treatment was assessed by comparing the Barthel ADL and
mobility scores at the beginning and the end of the period.
The associations of outcome with the demographic and
clinic predictors under investigation, obtained using bivar-
iate analysis, are summarized in Tables 2 and 3.
High TC was positively and significantly associated with
better home rehabilitative treatment outcome (Table 2).
Presence of IHD was negatively associated with treatment
outcome (Table 2). Age and SPMSQ score were also signif-
icantly associated with outcome using both Barthel ADL
and mobility scores. Barthel indices at admission appeared
to be negatively associated with outcome, because of
a ceiling effect (Table 3). Bivariate analysis failed to show
a statistically significant association between the comorbid-
ity index and rehabilitation program outcome (Table 3).
Similarly, stroke subtype was not associated with outcome
in either ADLs or mobility (Table 2).
Demographic and clinical characteristics were not
significantly different between the high TC patients and
those with normal TC levels (Table 4).
When the significant variables, i.e., high TC, presence of
IHD, SPMSQ score, and Barthel indices at admission,
Table 2
Outcome of the Rehabilitative Treatment Measured as Percent of Difference on Barthel Index Scores in Relation with the Categorical Variables Investigated
as Outcome Predictors. Results of the Bivariate Analysis (n 5 141 patients)
Predictor
Barthel ADL Index score means % differencea,b
p Valueb
Barthel mobility Index score means % differencea,b
p ValuebYES NO YES NO
Female gender 24.83 6 27.76 25.91 6 26.34 0.818 23.84 6 35.76 26.30 6 28.83 0.667
Hypercholesterolemia 37.14 6 29.23 21.77 6 25.57 0.004 39.55 6 33.14 20.49 6 21.95 0.003
Hypertension 25.54 6 28.16 23.87 6 21.77 0.784 24.23 6 33.59 27.70 6 31.03 0.641
Diabetes 30.18 6 27.94 22.47 6 26.39 0.104 24.61 6 35.60 24.93 6 31.79 0.956
Ischemic heart disease 18.77 6 23.56 31.47 6 28.95 0.005 18.62 6 24.59 30.75 6 18.82 0.029
Stroke subtype (OCSP)
LACI 29.60 6 28.98 0.505 27.14 6 19.67 0.957
PACI 21.63 6 22.64 23.30 6 16.98
POCI 20.60 6 18.56 23.50 6 31.81
TACI 24.60 6 16.24 24.99 6 27.84
ADL 5 Activities of Daily Living; LACI 5 Lacunar infarction; PACI 5 Partial anterior circulation infarction; POCI 5 Posterior circulation infarction;
TACI 5 Total anterior circulation infarction.
a Values are mean 6 SD.
b In bold statistically significant values.
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logistic regression analysis, only SPMSQ score and high
TC were consistently associated with better scores on both
Barthel indices (Table 5).Discussion
The current study adds to the mounting evidence that
patients with high TC levels have better functional
outcomes following rehabilitation. Indeed, corroboratingTable 3
Outcome of the Rehabilitative Treatment Measured as Percentage Change Barthe
Outcome Predictors, After Stratifying According to the Quartile Values. Results
Predictor
Barthel ADL Index
score means % differencea
Age class (y)c
53-72 (n 5 36) 33.82 6 23.79
73-79 (n 5 40) 27.09 6 29.35
80-84 (n 5 29) 21.80 6 17.43
85-94 (n 5 34) 15.92 6 23.38
Comorbidity indexc
0.09-1.84 (n 5 40) 24.23 6 24.87
1.85-2.23 (n 5 43) 30.65 6 29.93
2.24-2.38 (n 5 27) 22.95 6 19.22
2.39-3.69 (n 5 31) 21.12 6 13.82
SPQMQ scorec
0-3 (n 5 50) 36.94 6 27.15
4-7 (n 5 44) 24.20 6 18.39
Barthel ADL at admissionc
!46 (n 5 36) 58.98 6 1.86
46-53 (n 5 35) 49.83 6 2.09
O53 (n 5 70) 36.11 6 7.56
Barthel mobility at admissionc
!34 (n 5 36)
35-38 (n 5 38)
O38 (n 5 67)
ADL 5 Activities of Daily Living; SPQMQ 5 Short Portable Mental Status
a Values are mean 6 SD.
b In bold statistically significant values.
c In brackets number of patients by stratum.the results of previous studies, in our patients only SPMSQ
score and TC showed a significant association with func-
tional outcome following the home rehabilitative program.
SPMSQ score is largely known to be negatively associated
with stroke outcomes, thus the positive association between
rehabilitation outcome and higher levels of TC in both
bivariate analysis and after adjusting for confounding
factors is of particular interest.
Little is known about the prognostic role of cholesterol
on functional outcome after a stroke. Several authorsl Indices Scores in Relation with the Quantitative Variables Investigated as
of the Bivariate Analysis (n 5 141 patients)
p Valueb
Barthel mobility Index
score means % differencea p Valueb
















Main Demographic and Clinical Characteristics of the Patients Under








Female gender 18 (56.3) 67 (61.5) 0.30
Age 75.12 6 7.30 77.97 6 9.39 0.12
Diabetes mellitus 11 (34.4) 40 (36.7) 0.41
Ischemic heart disease 14 (43.8) 55 (50.5) 0.26
Hypertension 89 (87.5) 28 (81.7) 0.23
CIRS comorbidity index 2.23 6 0.43 2.09 6 0.47 0.16
SPQMQ score 4.84 6 3.93 5.54 6 3.64 0.35
Admit Barthel ADL
Index score
48.31 6 11.54 51.61 6 9.84 0.11
Admit Barthel mobility
Index score
35.59 6 5.37 36.47 6 5.95 0.46
Rehabilitation treatment days 77.41 6 33.18 67.45 6 35.50 0.16
a TC 5 serum total cholesterol.
b Values are mean 6 SD or n (%) unless otherwise stated.
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survival in patients with sequelae of stroke and all have
found that higher TC levels were associated with a lower
risk of death. Dyker et al. [20] first analyzed the influence
of TC on survival after stroke and found that higher serum
TC level was associated with lower 3-month overall
mortality. However, data examining the relationship
between TC and the dynamic process of functional
recovery after a stroke are lacking. Previous studies [20-
25] have reported an inverse association between serum
cholesterol levels and severity of stroke, suggesting that
higher levels of serum cholesterol could be associated with
so-called minor ischemic strokes. Vauthey [21] and Zuliani
et al. [22] reported that patients with high TC levels had
a lower risk of death or poor functional outcome in the first
month after ischemic stroke. More recently, this association
has been confirmed by the study of Pan et al. [25]. By using
serial Barthel Index scores until 6 months after stroke as theTable 5
Multivariable Logistic Regression Analysis of the Prognostic Factors,
After Dichotomizing the Barthel Percentage Changes (Positive Versus
Negative or Zero Values)
Variablea AOR (95% CI)b p Value
Barthel ADL Age 0.96 (0.91-1.00) 0.07
Gender (female) 0.69 (0.29-1.66) 0.41
SPQMQ score 0.85 (0.74-0.97) 0.02




Barthel mobility Age 0.90 (0.94-0.99) 0.02
Gender (female) 0.53 (0.22-1.24) 0.14
SPQMQ score 0.83 (0.74-0.94) !0.05




a In bold statistically significant values.
b AOR 5 adjusted odds ratio.
c TC 5 serum total cholesterol.main outcome measures, Pan et al. demonstrated that the
serum TC level at the acute stage of ischemic stroke is an
independent predictor of long-term functional outcome.
Furthermore, although the size of ischemic injury has
undoubtedly proven to be predictive of functional outcome,
even after adjusting for the effects of lesion size and base-
line Barthel index scores, cholesterol was still a significant
prognostic factor related to better rehabilitation outcome
[20-27].
This implies that favorable functional results in the pres-
ence of high cholesterol levels cannot be fully explained by
the association between high cholesterol and strokes of
minor severity. As a matter of fact, at this moment there
are no established biologic mechanisms that explain these
results. Some studies have suggested a neuroprotective role
of cholesterol that could be attributed to its antioxidant
properties [28]. Other studies have suggested that low
HDL cholesterol in the blood enhances the action of
platelet aggregation by acting on the platelet activating
factor [29,30]. In addition, high concentrations of choles-
terol might have a neuroprotective effect by modulating
the action of the gamma glutamyltransferase and acetylcho-
linesterase enzymes [31]. Alternately, other authors suggest
that lower TC levels in elderly patients may be a proxy for
poorer general health status and/or malnutrition, both
conditions leading to adverse functional outcomes [32].
Another issue to consider is a possible favorable effect
of the traditional Mediterranean diet that is likely adopted
by elderly patients during their lifetime in Sicily. It is
indeed well known that a Mediterranean diet can exert
protective effects against stroke and cardiovascular disease
via a number of its components, such as fruits and vegeta-
bles, whole grains, and fatty fish. All of these have been
associated with a reduction in the risk for stroke and hyper-
tension, the major modifiable risk factor for stroke [33,34].
Finally, a concerning finding in this study was the
number of patients with elevated TC levels who were not
on statin therapy. Although a number of guidelines have
been published supporting the effectiveness of statins in
reducing the risk of cardiovascular events, high variability
in the prescription of such drugs has been reported in
elderly people [35,36]. Indeed, only one fourth of patients
who are eligible for statin therapy received it, and numbers
are particularly low among individuals >75 years old
[35,36]. The undertreatment of high TC levels in elderly
persons can be attributed to a number of possible causes.
First, in some studies the predictive value of cholesterol
has been shown to decline with increasing age [35,36].
Second, statin treatment may be perceived as unlikely to
benefit older patients because of their theoretical short-
life expectancy [35,36]. Finally, physicians may have
misconceptions about the risk-benefit ratio of prescribing
statins to elderly patients with comorbidities [37]. In Italy
in particular, factors such as disability, cognitive impair-
ment, lack of a caregiver, and a low educational level
increase the probability of being untreated [35-37].
116 M.C. Cataldo et al. / Disability and Health Journal 5 (2012) 111e116This study has some limitations. All patients enrolled
were from the population admitted to the home care reha-
bilitative treatment program from a limited geographic
area, which could limit the generalizability of the results
obtained. Moreover, characteristics of the patients’ house-
hold settings were not investigated. Finally, the results of
the study need to be confirmed in a larger number of
patients across a wider spectrum of clinical and sociodemo-
graphic conditions.
Our study shows that elderly patients surviving a first-
time stroke exhibit better functional recovery if they have
higher TC levels. Further studies are needed to investigate
and confirm this finding, and to elucidate the mechanisms
underlying its positive effects.
References
[1] Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific
medical conditions on the functional limitations of elders in the Fra-
mingham study. Am J Public Health. 1994;84:351-358.
[2] Lefkovits J, Davis SM, Rossiter SC, et al. Acute stroke outcome:
effects of stroke type and risk factor. Aust N Z J Med. 1992;22:30-35.
[3] Pettersen R, Dahl T, Wyller TB. Prediction of long-term functional
outcome after stroke rehabilitation. Clin Rehabil. 2002;16:149-159.
[4] Francescutti C, Mariotti S, Simon G, D’Errigo P, Di Bidino R. The
impact of stroke in Italy: first step for a National Burden of Disease
Study. Disabil Rehabil. 2005;27(5):229-240.
[5] Franceschini M, Paolucci S, Perrero L, Polverelli M, Zampolini M,
Giustini A. Stroke rehabilitation care in Italy. Am J Phys Med Reha-
bil. 2009;88:679-685.
[6] Landau WM. Is cholesterol a risk factor for stroke? Arch Neurol.
1999;56:1521-1524.
[7] Tirschwell DL, Smith NL, Heckbert SR, et al. Association of choles-
terol with stroke risk varies in stroke subtypes and patient subgroups.
Neurology. 2004;63:1868-1875.
[8] Shepherd J, Blauw GJ, Murphy MB, et al. Prospective study of pra-
vastatin in the elderly at risk. Pravastatin in elderly individuals at risk
of vascular disease (PROSPER): a randomised controlled trial.
Lancet. 2002;360:1623-1630.
[9] Amarenco P, Bogousslavsky J, Callahan A, et al; Stroke prevention
by aggressive reduction in cholesterol levels (SPARCL) Investigators.
High-dose atorvastatin after stroke or transient ischemic attack. N
Engl J Med. 2006;355:549-559.
[10] Manktelow BN, Potter JF. Interventions in the management of serum
lipids for preventing stroke recurrence. Cochrane Database of
Systematic Reviews 2009, Issue 3. Art. No.: CD002091.
[11] Linee-guida del Ministro della Sanita per le attivita‘di riabilitazione
(in GU 30 maggio 1998, n. 124)Linee di indirizzo per la definizione
del percorso assistenziale ai pazienti con ictus cerebrale. Conferenza
Stato-Regioni-Repertorio Atti n. 2195 del 3 febbraio 2005, Gazzetta
Ufficiale n. 50.
[12] Pedersen PM, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS.
Comprehensive assessment of activities of daily living in stroke:
the Copenhagen Stroke Study. Arch Phys Med Rehabil. 1997;78:
161-165.
[13] Wade DT, Collen FM, Robb GF, Warlow CP. Physiotherapy interven-
tion late after stroke and mobility. BMJ. 1992;304:609-613.
[14] Kalra L. The influence of stroke unit rehabilitation on functional
recovery from stroke. Stroke. 1994;25:821-825.
[15] Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index.
Md State Med J. 1965;14:61-65.[16] Green J, Forster A, Young J. A test-retest reliability study of the Bar-
thel Index, the Rivermead Mobility Index, the Nottingham Extended
Activities of Daily Living Scale and the Frenchay Activities Index in
stroke patients. Disabil Rehabil. 2001;23:670-676.
[17] WHO task force. Stroke, 1989: recommendations on stroke preven-
tion, diagnosis, and therapy. Stroke 1989;20:1407-1431.
[18] Bamford JM, Sandercock PAG, Dennis MS, Burn J, Warlow CP.
Classification and natural history of clinically identifiable subtypes
of cerebral infarction. Lancet. 1991;337:1521-1526.
[19] Dyker AG, Weir CJ, Lees KR. Influence of cholesterol on survival
after stroke: retrospective study. BMJ. 1997;314:1584-1588.
[20] Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J.
Better outcome after stroke with higher serum cholesterol levels.
Neurology. 2000;54:1944-1949.
[21] Zuliani G, Cherubini A, Atti AR, et al. Low cholesterol levels are
associated with short-term mortality in older patients with ischemic
stroke. J Gerontol A Biol Sci Med Sci. 2004;59:293-297.
[22] Olsen TS, Christensen RH, Kammersgaard LP, Andersen KK. Higher
total serum cholesterol levels are associated with less severe strokes
and lower all-cause mortality: ten-year follow-up of ischemic strokes
in the Copenhagen Stroke Study. Stroke. 2007;38:2646-2651.
[23] Li W, Liu M, Wu B, et al. Serum lipid levels and 3-month prognosis
in Chinese patients with acute stroke. Adv Ther. 2008;25:329-341.
[24] Pan SL, Lien IN, Chen TH. Is higher serum total cholesterol level
associated with better long-term functional outcomes after noncar-
dioembolic ischemic stroke? Arch Phys Med Rehabil. 2010;91:
913-918.
[25] Beloosesky Y, Streifler JY, Burstin A, Grinblat J. The importance of
brain infarct size and location in predicting outcome after stroke. Age
Ageing. 1995;24:515-518.
[26] Johnston KC, Connors AF, Wagner DP, Haley EC. Predicting
outcome in ischemic stroke: external validation of predictive risk
models. Stroke. 2003;34:200-202.
[27] Simonsen U, Ehrnrooth E, Gerdes LU, et al. Functional properties
in vitro of systemic small arteries from rabbits fed a cholesterol-
rich diet for 12 weeks. Clin Sci. 1991;80:119-129.
[28] Joseph JA, Villalobos-Molinas R, Denisova NA, Erat S, Strain J.
Cholesterol: a two-edged sword in brain aging. Free Radic Biol
Med. 1997;22:455-462.
[29] Chui DH, Marotta F, Rao ML, et al. Cholesterol rich LDL perfused at
physiological LDL concentration induces platelet aggregation and
PAF-acetylhydrolase activation. Biomed Pharmacother. 1991;45:
37-42.
[30] Eryurek FG, Surmen E, Oner P, Altug T, Oz H. Gamma-glutamyl-
transpeptidase and acetylcholinesterase activities in brain capillaries
of cholesterol-fed rabbits. Res Commun Chem Pathol Pharmacol.
1990;69:245-248.
[31] Davalos A, Ricart W, Gonzalez-Huix F, et al. Effect of malnutrition
after acute stroke on clinical outcome. Stroke. 1996;27:1028-1032.
[32] Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of
stroke. Semin Neurol. 2006;26:11-23.
[33] Fung TT, Rexrode KM, Mantzoros CS, Manson JE, Willett WC,
Hu FB. Mediterranean diet and incidence of and mortality from coro-
nary heart disease and stroke in women. Circulation. 2009;119:
1093-1100.
[34] Maraldi C, Lattanzio F, Onder G, et al. Variability in the prescription
of cardiovascular medications in older patients: correlates and poten-
tial explanations. Drugs Aging. 2009;26(Suppl. 1):41-51.
[35] De Wilde S, Cook DG, Carey IM, Hilton SR, Whincup PH. Underuse
of statins among older people. Lancet. 2003;362:746-747.
[36] Landi F, Cesari M, Onder G, et al; SILVERNET-HC Study Group.
Antithrombotic drugs in secondary stroke prevention among
a community dwelling older population. J Neurol Neurosurg Psychi-
atry. 2003;74:1100-1104.
